HomeMarketsSharesParkwayLife Reit

Trade ParkwayLife Reit - C2PUsg CFD

Market is not available at the momentMarket information is presented
as of 2026-10-09T08:45:38+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.018
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
SGD 1,000.00
Overnight funding adjustment
Charges from full value of position
-0.014386 %
(-SGD 2.88)

Trade size with leverage ~ SGD 20,000.00

Money from leverage ~ $SGD 19,000.00


-0.01439%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
SGD 1,000.00
Overnight funding adjustment
Charges from full value of position
-0.007532 %
(-SGD 1.51)

Trade size with leverage ~ SGD 20,000.00

Money from leverage ~ $SGD 19,000.00


-0.00753%
Overnight funding adjustment time21:00 (UTC)
CurrencySGD
Min traded quantity10
Margin5.00%
Stock exchangeSingapore
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close3.966
Open3.976
1-Year Change-4.54%
Day's Range3.966 - 3.986

Trade ParkwayLife Reit - C2PUsg

About Parkway Life REIT

Parkway Life Real Estate Investment Trust is a Singapore-based healthcare real estate investment trust (REIT). The principal activity of the Company is to invest primarily in income-producing real estate and/or real estate-related assets in the Asia-Pacific region, including Singapore that are used primarily for healthcare and/or healthcare-related purposes, including hospitals, healthcare facilities and real estate and/or real estate assets used for healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices. Its segments include Hospital Properties, Nursing Home and Care Facility Properties and Medical Centre Units. Its portfolio includes about 56 properties. Its properties include Mount Elizabeth Hospital Property, Gleneagles Hospital Property, Parkway East Hospital Property, Bon Sejour Yokohama Shin-Yamashita, Palmary Inn Akashi, Sompo no le Nakasyo, Maison des Centenaire Haruki and Hapine Fukuoka Noke, among others.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Parkway Life REIT revenues decreased less than 1% to SP$120.7M. Net income increased from SP$87.2M to SP$331.9M. Revenues reflect Hospital and Medical Centre segment increase of 1% to SP$70.7M, Singapore segment increase of 1% to SP$70.4M, also reflect Pharmaceutical Manufacturing and Distribution Facility segment decrease of 93% to SP$128K, Japan segment decrease of 2% to SP$50M.

Equity composition

11/2009, Capital repayment of SGD 0.0014 01/2010, Capital repayment of SGD 0.0018 05/2010, Capital repayment of SGD 0.0029 08/2010, Capital repayment of SGD .003 11/2010, Capital repayment of SGD .0044 01/2011, Capital repayment of SGD .0044

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready